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Several cobalt-containing macrocyclic compounds have been examined for their ability to 
bind cyanide rapidly with a large association constant.  These macrocycles were synthesized and 
studied, resulting in one in particular (CobaltIII meso-tetra(4-N-methylpyridyl)porphine 
(CoIIITMPyP)) having the physical characteristics necessary for potential use as a cyanide 
antidote.  The binding of cyanide to the oxidized form, forming CoIIITMPyP(CN)2, at pH 7.4, 
25°C, has been shown to be completely cooperative (αH = 2) with an association constant of 2.1 
± 0.2 x 1011.  The kinetics were investigated by stopped-flow spectrophotometry and revealed a 
complicated net reaction exhibiting four phases at pH 7.4 under conditions where cyanide was in 
excess.  The data suggest molecular HCN (rather than CN-) to be the attacking nucleophile 
around neutrality.  Additionally, the administration of CoIIITMPyP one minute after a lethal dose 
of cyanide to mice resulted in a marked increase in survival (67%) compared to controls (33%). 
The time required for the CoIIITMPyP-treated mice to right themselves from a supine position 
was also significantly decreased (9 ± 2 min.) compared to the controls (33 ± 2 min.). 
Since blood contains ascorbate, the rate of reduction of CoIIITMPyP by ascorbate is of 
interest.  Indeed, the rate of reduction of CoIIITMPyP by ascorbate is fast, with second order rate 
constants of 8.3 x 104 M-1s-1 at 25°C and 1.4 x 105 M-1s-1 at 37°C.  Addition of cyanide to 
CoIITMPyP results in the binding of cyanide as evidenced by electric paramagnetic resonance 
spectroscopy but cyclic voltammetry and kinetic investigations indicate that cyanide induces 
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oxidation to the CoIII dicyano species.  The equilibrium binding constant derived from the 
addition of cyanide to the reduced form was found to be 2.1 ± 0.1 x 1010 (Kβ), at pH 7.4, 25°C.  
Electron paramagnetic resonance spectra of mouse blood taken after the addition of the 
CoIIITMPyP show that the cobalt is reduced and that subsequent addition of cyanide to the blood 
results in the disappearance of this signal indicating that cyanide scavenging has taken place. 
The kinetics of cyanide binding to CoIITMPyP are complicated; four phases were found, which 
were shown to be dependent on the cyanide concentration.  A mechanism for the binding of 
cyanide to the reduced form is proposed.   
With regard to public health, HCN is a known toxic component of modern fires and 
smoke inhalation victims are probably the most frequent patients exhibiting symptoms of acute 
cyanide toxicity presenting at emergency rooms in Europe and the U.S.  Furthermore, there is a 
paucity of effective cyanide antidotes at present.  As such, the development of efficacious 
cyanide antidotes is desirable.   
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1.0  INTRODUCTION 
1.1 CYANIDE EXPOSURE & TOXICITY 
Humans are primarily exposed to cyanide in two ways.1 First, through inhalation of
contaminated air, including tobacco smoke; and, second, by ingestion of foods derived from 
cyanogenic plants.  Exposure through air is usually a continuous, low-dose (i.e. chronic) process, 
but with the important exception of more acute exposure through modern fire smoke.2  In the
third world, chronic toxicity associated with diets high in cassava and/or sorghum products is a 
major concern.3  Consumption of cyanide-laced foods or beverages can, however, result in
symptoms of both acute and chronic cyanide poisoning.1  Failed suicide attempts by ingestion
have traditionally represented the most common cases of potentially treatable cyanide 
intoxications presenting in the emergency room with acute symptoms.4  Consumption of
cyanogenic plant materials by livestock5 is the most common form of acute cyanide poisoning
encountered in the U.S. today.  At least in this country, accidental exposures during 
industrial/mining operations are of relatively low concern.6 Recent research efforts in the field of
antidotes/countermeasures to acute toxicity have largely been driven by the fear that the 
deliberate release of HCN in confined spaces (e.g., modern buildings, mass-transit vehicles, 
tunnels etc.) might prove an effective means for terrorists to inflict mass casualties on a targeted 
population.7 
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Aside from the ubiquitous low-dose exposures and the subsiding fear of chemical 
terrorism mentioned above, the route of exposure, at present, by which acute hydrogen cyanide 
exposure typically occurs is via the inhalation of fire smoke.  Such exposure is made possible by 
the increasing prevalence of anthropogenic polymeric material (e.g., plastics) that contains 
nitrogen.  Namely, products such as nylon, polyurethane, and polyacrylonitrile release hydrogen 
cyanide when in the presence of a hot, enclosed fire.  Moreover, the numerous components of 
fire smoke (e.g., carbon monoxide) pose the possibility of a synergistically toxic impact upon 
fire victims and first responders.2
The molecular mechanism(s) by which chronic cyanide toxicity impacts human health 
is(are) unknown.  The levels at which suspected health problems linked to chronic cyanide 
exposure have been epidemiologically identified8 are not currently known to be associated with
significant inhibition or down regulation of any enzyme systems, or other critical biomolecules.  
Acute cyanide toxicity, on the other hand, is clearly associated with inhibition of cytochrome c 
oxidase, also known as complex IV of the mitochondrial electron-transport chain.1,9,10  Dozens of
other enzyme systems may be affected, but only at orders-of-magnitude higher levels of the 
toxin.  It has been pointed out11 that inhibition of these other enzymes occurs in patients who are
treated while undergoing slow gastric cyanide absorption having ingested many times the LD50 
dose.  It is quite inappropriate to suggest that inhibition of anything other than complex IV is 
lethal in the acute scenario.  Whatever else is alleviated, any successful therapy must restore 
electron-transport chain (ETC) activity by overcoming cyanide inhibition of complex IV.  The 
most sensitive tissue to mitochondrial inhibition seems to be the central nervous system (CNS) 
and the autonomic nervous system serving respiration particularly so.  Consequently, death by 
acute cyanide poisoning is due to respiratory failure1,9,10 and follows within 1-2 minutes of an
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injected or inhaled lethal toxic dose.  Sub-lethal toxicity in relation to fire smoke is also an 
emerging concern because a symptom of sub-lethal cyanide intoxication is disorientation and 
narcosis.  It is thought that this symptom of sub-lethal intoxication in fire victims can lead to 
poor escape decisions being made resulting in deaths that might otherwise have been avoided.2,12
Certainly, the large number of facilities using cyanide salts and their broad distribution 
throughout the U.S.13 is extremely worrying with regard to the possible theft of said cyanides for
other criminal purposes.  These concerns, regarding the possibility of imminent cyanide chemical 
terrorism, have repeatedly been re-stated in the recent emergency preparedness literature.14-18 
1.2 EXTANT CYANIDE ANTIDOTES 
1.2.1 Sodium Nitrite 
For more than half a century, the combined administration of intravenous sodium nitrite 
solution followed by sodium thiosulfate solution was the standard therapy for cyanide poisoning 
in the U.S.  This type of cyanide antidote kit is still carried by medical emergency response 
teams.  The sodium nitrite component of the kit was believed to function by oxidizing 
deoxyhemoglobin to methemoglobin in the bloodstream.19  Methemoglobin has a reasonable
binding affinity for cyanide and should therefore lower the level of circulating free cyanide 
(HCN + CN–) thereby ameliorating toxicity.  There are, however, several lines of evidence
showing this previously accepted mechanism to be wrong:20  (i) if methemoglobin formation is
suppressed, sodium nitrite is still fully protective;21  (ii) the formation of methemoglobin is
known to lag behind the beneficial effect of nitrites;22  (iii) nitrite is antidotal to cyanide in
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cultured cells not containing any hemoglobin, or significant levels of other oxygen transport 
hemoproteins;23-25  (iv) toxicity is ameliorated when the level of circulating cyanide is an order
of magnitude greater than the nitrite level.20  It is to be stressed that sodium nitrite is certainly an
effective and rapidly acting cyanide antidote, but its mode of action is almost certainly through 
its NO-donor capability20 as NO is able to reverse cyanide inhibition of cytochrome c
oxidase.25,26  Another important matter is that sodium nitrite alone is an effective cyanide
antidote, giving the other component of the old standard combination therapy, sodium 
thiosulfate, is only beneficial if slow absorption of more than 4 x LD50 of the toxin is the case.
27
1.2.2 Sodium Thiosulfate 
Thiosulfate is a substrate for the enzyme rhodanese that converts cyanide to the much less 
toxic thiocyanate anion, which is excreted through the kidneys.19 Intriguingly, rhodanese activity
is concentrated in the liver and kidneys rather than the CNS where it is principally required for 
maximal antidotal effect toward cyanide.  This issue aside, in sub-lethal scenarios of cyanide 
intoxication, thiosulfate is not beneficial and actually makes matters worse;28 seemingly, by a
reaction with blood leading to production of sulfide, which is comparably toxic to cyanide.20
There are better and considerably less toxic sulfur-donor type cyanide antidotes currently under 
development.29,30 
1.2.3 Hydroxocobalamin 
“Cobalamin” (i.e., hydroxocobalamin, vitamin B12) is a cobalt
III-containing corrinoid
structure (Figure 1) that is able to bind cyanide anion in the bloodstream and, thus, works as an 
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antidote by lowering the toxic level of circulating free cyanide.  It has been available for 
emergency medical use in Europe for a number of years and has more recently been approved for 
use in the U.S.  Interestingly, intravenous cobalamin is used to treat “acute” cyanide poisoning in 
victims of smoke inhalation, often an hour or more after they have been removed from the 
cyanide source.31-33  In truly acute scenarios death is within minutes if lethal doses are involved
and at sub-lethal doses the effects of cyanide requiring intervention do not seem to persist for 
more than 30-60 minutes.20  Consequently, fire smoke inhalation, where the toxic dose can be
spread over many minutes, appears to include both acute and more chronic patterns of cyanide 
intoxication.  If smoke inhalation patients benefit from cyanide-decorporation procedures hours 
after the exposure to the source has ceased, there must be a presently undelineated 
pathobiochemistry where cyanide becomes anabolically “fixed” during the exposure and then 
slowly released as HCN later in the clinic.  Nevertheless, despite the mechanistic uncertainty, 
much evidence abounds31-33 that there is some value in this type of treatment and it follows that
development of improved cyanide-scavenging agents is desirable. 
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Figure 1:  Chemical structure of cobalamin and cobinamide. 
1.2.4 Cobinamide 
Cobalamin is a less than ideal cyanide scavenger and its biological precursor, cobinamide 
(Figure 1), has been shown to be 3-10 times more effective in animal studies.34,35  Both of these
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rather complicated biomolecules are, however, expensive to produce commercially, cobinamide 
the more so.  Cobinamide clearly has two axial ligand positions available to bind cyanide, 
compared with the single available axial position in cobalamin. 
1.2.5 Other Potential Antidotes 
The conjugate bases of certain keto acids, like pyruvate and -ketoglutarate, are able to 
trap cyanide as the essentially non-toxic cyanohydrins, thereby affording a mechanism in vivo of 
lowering the level of any free cyanide present.  It is not surprising then that -ketoglutarate, in 
particular, has been periodically reported to offer at least prophylactic protection against cyanide 
intoxication.36-39  Furthermore, an auxiliary role for molecular oxygen in the antidotal effect has
been suggested37 even though oxygen cannot displace cyanide from cytochrome c oxidase.24,26
Oxygen is, however, also a substrate for nitric oxide synthase and the antidotal effect of 
supplemental oxygen could be due to production of NO, which clearly is protective.20 
1.3 ATTEMPTED CYANIDE ANTIDOTES 
Given the proclivity of hydroxocobalamin and cobinamide to stably bind cyanide, it is 
useful to probe into the nature of that ability.  A cursory purview of the compounds suggests that 
the cobaltIII state of oxidation is an important factor.  Indeed, cobaltIII-containing macrocycles
provide a stable electronic environment as they contain 18 valence electrons given the octahedral 
complex that is formed.40   Such a configuration for transition elements is akin to the application
of the “octet rule” to main group elements as said configuration results in all the molecular 
8 
orbitals of a transition element possessing a pair of electrons.  As such, the pursuit of cobaltIII-
containing macrocycles underscored the following attempts to produce alternate antidotes to 
counter acute cyanide toxicity.  
1.3.1 CobaltIII Tetramido Macrocycles
The genesis for this project involved the pursuit of a novel class of cobaltIII-containing
macrocycles that would serve as cyanide scavenging agents.  Macrocyclic tetramides, in 
particular, have been shown to stably bind cobaltIII.41 That compound is synthetically complex
rendering it too expensive for the aims of this project.  Nonetheless, it provides a useful proxy 
about which to contemplate similar, tetramido, compounds.  In that vein, altogether insoluble 
tetramido macrocycles have long been known.42 These macrocycles alternate amido-linkages
with pyridinyl moieties and provides another proxy about which to design a novel class of 
tetramido-compounds.  Ultimately, macrocyclic tetramides in which amido-linkages alternated 
with phenyl moieties were pursued.  The selection of phenyl moieties is useful in that the 
phenylenediamine starting materials necessary to produce a tetramido macrocycle exist with 
modifiable pendant functional groups so as to provide a synthetic route to aqueous solubility.  
Lastly, a study of a similar compound that served as an anion receptor43 suggested that an
anionic template would serve as an aid to synthetic yield and purity.  
At the outset, the tetramido macrocycles were deemed to possess a number of especially 
desirable properties for development as pharmaceuticals.  The targeted compounds (e.g., Figure 
2) can be synthesized in a small number of steps from inexpensive starting materials.  Precisely
because they are macrocyclic they should be relatively stable; that is, not require refrigeration – 
an advantage for stockpiling.  Also, this stability should translate into minimal problems with 
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toxicity – given the similarities, these compounds should have comparably modest toxicities and 
be excreted in the same fashion as porphyrins and phthalocyanines.44,45  The required ability to
bind two cyanide anions with suitable affinity and at reasonable reaction rate could be practically 
guaranteed given they would finally contain CoIII in a roughly square-planar arrangement of
nitrogen donors with two axial positions available for ligand substitutions (Figure 2).  Therefore, 
one should be able to set about fine-tuning their other characteristics by suitable derivatization 
(introducing additional functionalities on either or both of the starting materials) without 
eliminating the critical required cyanide-binding property. 
Unfortunately, purification of these compounds was found to be extremely difficult and 
cobalt insertion was never confirmed – either directly, or indirectly by cyanide binding to 
preparations.   
Figure 2: Chemical structure of the proposed CoIII-containing tetramido macrocycle. 
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1.3.2 CobaltIII Phthalocyanines
Phthalocyanines are structurally similar to the corrinoid structure of hydroxocobalamin.  
Likewise, they readily complex cobalt (albeit as cobaltII requiring a subsequent oxidation to
cobaltIII once fashioned) in a manner that leaves two axial ligand positions available to bind
cyanide anions.46  There is a plethora of existing derivatization chemistry already documented
for phthalocyanines46 and several known peripheral substituents render phthalocyanines soluble
in water.  Therefore, there were obvious and attractive reasons to suppose that CoIII
phthalocyanines might be useful compounds pursuant to the goals of this project. 
1.3.2.1 CobaltII 4,4’,4”,4’”-tetrasulfophthalocyanine
CobaltII 4,4’,4”,4’”-tetrasulfophthalocyanine (CoII-TSPc) can be synthesized in one step
from commercially available starting materials and is soluble in aqueous media.47   CoII-TSPc
undergoes a single electron oxidation to CoIII-TSPc in the presence of cyanide.48  It was found,
however, that under physiologically relevant concentrations of cyanide, the oxidation and 
binding of cyanide proceeds too slowly (a time scale of days) to further pursue CoII-TSPc as a
potential antidote to acute cyanide toxicity.  
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Figure 3: Chemical structure of CobaltII 4,4’,4”,4’”-tetrasulfophthalocyanine (R = SO3
-) and CobaltII 
4,4’,4”,4’”-tetraaminophthalocyanine (R= NH4
+).
1.3.2.2 CobaltII 4,4’,4”,4’”-tetraminophthalocyanine
At physiologic pH, CobaltII 4,4’,4”,4’”-tetraminophthalocyanine (CoIITAPc) was found
to be insoluble and further study was abandoned. 
1.3.3 CobaltIII meso tetra(4-N-methylpyridyl)porphine
CobaltIII meso-tetra(4-N-methylpyridyl) (CoIIITMPyP) has been widely studied and can
be synthesized in three steps from commercially available starting materials in reasonable 
yield.49-53  CoIIITMPyP is monomeric over a wide range of pH49 and thus, has the required two
axial ligand positions available to bind cyanide anions suggesting an ability to be as efficacious 
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as cobinamide.  In noting these qualities, CoIIITMPyP was focused upon for all further study that
comprises the dissertation.  
1.4 SCOPE OF THE DISSERTATION AND STATEMENT OF HYPOTHESIS 
Based on the premise that having two axial ligand positions available to bind cyanide 
anions must be the key structural advantage of cobinamide over cobalamin, the hypothesis that 
other, less expensive to produce, cobaltIII-containing macrocyclic structures with their two axial
ligand-binding positions available should have useful cyanide scavenging capabilities is 
proposed.  The likelihood of this proposal not being correct must surely be remote in the extreme 
– much of what is thought to be known about cyanide toxicity and how to ameliorate it would
have to be significantly incorrect – and, indeed, the present studies with CoIIITMPyP have
ultimately supported the hypothesis (Chapter 3).  Perhaps the more intriguing previously 
reported54 observation is that CoTMPyP does not work prophylactically as a cyanide antidote.
Reasoning that reduction of the compound to CoIITMPyP by ascorbate would occur in vivo,
additional reasoning suggested that this would lead to deactivation of cyanide binding capability 
and absence of prophylaxis and set out to test this second hypothesis (Chapter 4).  
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2.0  MATERIALS & METHODS 
2.1 MATERIALS 
All reagents were ACS grade, or better, used without further purification and, unless 
otherwise noted, purchased from Aldrich or Sigma.  Argon gas (99.998%) was acquired from 
Matheson.  Concentrations of bovine serum albumin (BSA) solutions were determined 
spectrophotometrically using the average extinction coefficient.55 Cobinamide was a kind gift
from Prof. Gerry Boss, U. of California, San Diego. 
2.2 INSTRUMENTATION 
A Vacuum Atmospheres Company Omni-Lab glove box, equipped with an electrolytic 
fuel cell to measure oxygen levels to below 1 part per million, was used to provide an anaerobic 
environment when necessary.  Shimadzu UV-1650PC and UV-2501PC spectrophotometers were 
employed for the measurement of electronic absorption spectra and photometric titrations.  
Stopped-flow kinetics were measured with an Applied Photophysics stopped-flow/laser-flash 
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spectrometer (LKS.60-SX.18MV-R system) (figure 4) and the resultant data was fit with the PC 
Pro-K software (!SX.18MV) provided by the manufacturer.  Cyclic voltammetry was performed 
using a Princeton Applied Research Potentiostat/galvanometer 283.  X-band (9 GHz) electron 
paramagnetic resonance (EPR) spectra were recorded on a Bruker ESP 300 spectrometer 
equipped with an Oxford ESR 910 cryostat for ultra-low-temperature measurements.  The 
microwave frequency was calibrated by a frequency counter and the magnetic field was 
calibrated with a gauss meter.  This instrument was obtained with the assistance of a shared-
instrumentation grant (NSF) and is maintained at Carnegie Mellon University.  The software 
(SpinCount) used to analyze the EPR spectra was graciously provided by Professor Mike 
Hendrich, Carnegie Mellon University.  A Finnegan LCQ quadrupole field ion trap mass 
spectrometer equipped with an electrospray ionization source (ESI-MS) was provided by 
Professor Mark Bier, Carnegie Mellon University.  
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Figure 4: A schematic of a typical stopped-flow design.  
The stopping mechanism in this iteration is the stop syringe.  Two drive syringes (C and F) contain 
reactants.  The drive ram engages the syringes’ pistons so that reactants are pushed through their respective 
tubing into a mixer and, finally, the observation cell.  The prior contents of the cell are consequentially 
pushed through the waste tubing, impacting the stop syringe until it triggers a switch that stops the flow 
while also initiating the collection of data.  The reactants, at this point in time, have been mixed in the 
observation cell for roughly one millisecond.  Determination of the exact time between mixing and data 
collection (the dead time) is dependent upon the design of both the stopped-flow instrument and the 
observation cell.  This figure was adopted from Applied Photophysics Ltd.56
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2.3 SYNTHESES 
Figure 5:  The reaction scheme by which the final product of Chapter 2.3.1 is acquired. 
2.3.1 CoIII tetramido macrocycles
Equimolar quantities of 4-nitro-o-phenylenediamine and isophthaloyl dichloride were 
condensed at room temperature in methyl ethyl ketone (MEK) in the presence of catalytic 
quantities of triethylamine and tetramethylammonium chloride.  The reaction was performed via 
the concurrent addition of both starting materials (as dissolved in MEK) via dropping funnels to 
a round bottom flask containing catalysts dissolved in MEK, under argon, over a period of two 
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hours. The resultant macrocycle (Figure 5) precipitated from solution along with 
triethylamine•HCl byproduct.  The product was washed with 1M aqueous hydrochloric acid 
effectively removing the contaminating byproduct as confirmed by ESI-MS (Figure 6).  The 
three peaks of the anionic mass spectrum correlate to the product with a loss of a proton (m/z 
565), the product binding a chloride anion (m/z 601), and either an octomeric macrocycle binding 
a chloride anion or a sandwich complex consisting of two molecules of the product binding a 
single chloride anion (m/z 1167).  The lack of hexameric or decameric macrocycles in the 
anionic mass spectrum suggests that the final peak is, indeed, a sandwich complex.  A yield of 
~50% was reliably recovered.  
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Figure 6: ESI-MS anionic mass spectrum providing evidence of the relatively pure product of 
Chapter 2.3.1. 
The three peaks of the anionic mass spectrum correlate to the product with a loss of a proton (m/z 565), the 
product binding a chloride anion (m/z 601), and a sandwich complex consisting of two molecules of the 
product binding a single chloride anion (m/z 1167). 
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2.3.2 CoII phthalocyanines
2.3.2.1 CoII 4,4’,4”,4’”-tetrasulfophthalocyanine
The procedure below was conducted via the methods of Weber and Busch.47 The
trisodium salt of 4-sulfophthalic acid, Cobalt chloride, ammonium chloride, ammonium 
molybdate, and urea were placed in a mortar and ground into a homogenous mixture with a 
pestle.  Meanwhile, nitrobenzene was added to a round-bottomed flask and heated to 180°C in an 
oil bath.  To the flask, the solid mixture was added in a piecemeal fashion over the course of an 
hour.  The resultant, heterogeneous mixture was stirred for 6 hours while the temperature was 
maintained at 180°C.  Next, the product was washed with methanol, repeatedly, until the aroma 
of nitrobenzene was no longer present.  The refined product was then subjected to 1 M (aq) 
hydrochloric acid that was saturated with sodium chloride and briefly refluxed.  Upon cooling, 
undissolved product was filtered and dissolved in 100 mM (aq) sodium hydroxide.  Said solution 
was heated to 80°C after which impurities precipitated and were filtered.  To cooled solution, 
sodium chloride was added.  Upon stirring and heating to 80°C ammonia evolved and product 
precipitated.  Once such evolution ceased, the product was collected via filtration.  The noted 
acid and base washes were twice repeated. 
2.3.2.2 CoII4,4’,4”,4’”-tetraaminophthalocyanine
The procedure below was conducted via the methods of Achar et al.57 4-nitrophthalic
acid, cobalt chloride, ammonium chloride, ammonium molybdate and urea were placed in a 
mortar and ground into a homogenous mixture with a pestle.  Meanwhile, nitrobenzene was 
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added to a round-bottomed flask and heated to 180°C in an oil bath.  To the flask, the solid 
mixture was added in a piecemeal fashion over the course of an hour.  The resultant, 
heterogeneous mixture was stirred for 6 hours while the temperature was maintained at 180°C. 
Next, the product was washed with methanol, repeatedly, until the aroma of nitrobenzene was no 
longer present.  The refined product was then subjected to 1 M (aq) hydrochloric acid that was 
saturated with sodium chloride and briefly refluxed.  Upon cooling, undissolved product was 
filtered and dissolved in 100 mM (aq) sodium hydroxide.  Said solution was heated to 80°C, 
after which impurities precipitated and were filtered.  To cooled solution, sodium chloride was 
added.  Upon stirring and heating to 80°C ammonia evolved and product precipitated.  Once 
such evolution ceased, the final product, CoII 4,4’,4”,4’”-tetranitrophthalocyanine (CoTNPc),
was collected via filtration.  The noted acid and base washes were twice repeated.  To form the 
tetraamine, CoTNPc was slurried in water to which sodium sulfide nonahydrate was added and 
stirred at 50°C for 5 hours.  The resultant solid was filtered and slurried with 1 M (aq) 
hydrochloric acid.  Product was again filtered and slurried with 1 M (aq) sodium hydroxide.  
Lastly, the product was washed with copious amounts of water prior to being dried in an oven at 
100°C for 1 hour. 
2.3.3 CoIII meso tetra(4-N-methylpyridyl)porphine
H2TMPyP was synthesized by the method of Hambright et al.
49 Cobalt was inserted into
the macrocycle using the method of Pasternack et al.50    Briefly, CoCl2 was refluxed under
argon with aqueous H2TMPyP overnight.  Upon cooling, the resultant Co
IIITMPyP was
precipitated with excess potassium iodide. The flat brown flakes of precipitated 
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metalloporphyrin iodide were then dissolved in a 5% acetone aqueous solution and re-
precipitated with excess potassium iodide.  The final solid product was filtered from the mixture, 
washed with dilute aqueous potassium iodide, and dried in an oven at 100°C for 1 hour. 
2.4 METHODS 
2.4.1 Anaerobiosis 
When a critical anaerobic environment was required, work was conducted in a glove box 
equipped with an argon atmosphere.  Less critically, a vacuum manifold was repurposed with 
argon and employed to reconfigure the environment of septum sealed cuvettes.  
2.4.2 Titration experiments 
For determinations of cyanide binding equilibria all solutions were maintained in 
“capped” (septum sealed, with head volumes minimized) vessels and transfers made with gas-
tight syringes.  Small aliquots of relatively concentrated cyanide solutions (buffered with 50 mM 
sodium borate; pH 11) were titrated into larger volumes of relatively dilute solutions of 
CoIIITMPyP (buffered with 50 mM sodium phosphate and 1 mM EDTA; pH 7.4) to maintain
neutrality at both 25°C and 37°C.  As multiple fast and slow cyanide binding forms are feasible, 
solutions were allowed to equilibrate for ~10 minutes after the addition of cyanide prior to 
recording the resultant absorption changes, by which time constant readings were obtained.  
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Binding constants were determined by the construction of Hill plots. The saturation of the 
CoIIITMPyP with cyanide was determined from the absorbance changes, where Y represents the
proportion of sites occupied by cyanide (or fractional saturation) was plotted against the 
concentration of the free cyanide concentrations.   Fits of the data yielded cooperativity values 
and binding constants for the association of cyanide to CoIIITMPyP.
2.4.3 Kinetics experiments 
All reactions (cyanide, azide, or ascorbate) were run under pseudo first order conditions 
and the temperature controlled by a thermostatted reaction chamber.  The individual rates 
observed are the average of at least three runs.  The average deviation of these runs is less than 
5%. Rate constants were then obtained from linear fits to the observed rates versus the substrate: 
total cyanide (CN- + HCN), sodium azide, or sodium ascorbate.  Rapid reaction kinetics were 
performed with a stopped-flow spectrophotometer. 
2.4.4 Animals, exposures, and righting recovery determinations 
All animal procedures were approved by the University of Pittsburgh Institutional 
Animal Care and Use Committee (Protocol Number 1008725).  Veterinary care was provided by 
the Division of Laboratory Animal Research of the University of Pittsburgh.  Male Swiss 
Webster (CFW) mice weighing 35-45 g were purchased from Charles River Laboratories, 
Wilmington, MA.  All animals were 16-20 weeks old and were housed four per cage.  The mice 
were allowed access to food and water ad lib. and experiments commenced after the animals 
were allowed to adapt to their new environment for one week.  All solutions were administered 
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through ~0.1 mL intraperitoneal (i.p.) injections.  At the end of exposures and tests, mice were 
euthanized with 150 mg/kg (i.p.) sodium pentobarbital followed by cervical dislocation. 
Righting recovery times were assessed based on the method of Crankshaw et al.29 with minor
changes as described by Cambal et al.20 Following injections, mice were placed in clear plastic
tubes in a supine position.  The time from the cyanide injection until the mouse flipped from a 
supine to a prone position in the plastic tube was taken as the endpoint.  After righting, the tube 
was rolled to make sure the mouse could maintain the prone position, thereby avoiding false 
positive results. Trials were conducted with three different experiments: saline, 5 mg/kg sodium 
cyanide, and 20.8 mg/kg CoIIITMPyP.
2.4.5 Cyclic voltammetry 
Cyclic voltammograms were acquired from relatively dilute solutions of CoIIITMPyP in
excess cyanide (1 mM), 0.1 M NaNO3, 50 mM phosphate buffer at pH 7.4 at 25°C under argon. 
A three-electrode configuration was employed.  Polished platinum wire was used as both the 
working and counter electrode. A Ag|AgCl|KCl(sat.) electrode was used as a reference electrode. 
All potentials were reported with respect to this reference electrode. 
2.4.6 Electron paramagnetic resonance 
The following methods employed have previously been well established in this 
laboratory.58-60 Quantification of EPR signals was performed by simulating the spectra using
known (or determined) parameters for each sample in question.  Simulations employed a least-
squares fitting method to match the line shape and signal intensity of a selected spectrum.   
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Simulated spectra were expressed in terms of an absolute intensity scale, which could then be 
related to sample concentration through comparison with a CuII(EDTA) spin standard of known
concentration. 
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3.0  THE METALLOPORPHYRIN CoIIITMPyP AMERLIORATES
ACUTE SUB LETHAL CYANIDE TOXICITY IN MICE 
Oscar S. Benz, Quan Yuan, Linda L. Pearce and Jim Peterson 
Department of Environmental and Occupational Health, Graduate School of Public 
Health, The University of Pittsburgh, 100 Technology Dr., Pittsburgh, Pennsylvania 15219, USA 
[Adapted from a publication98 in Chemical Research in Toxicology]
3.1 ABSTRACT 
The administration of CoIIITMPyP one minute after a lethal dose of cyanide to mice
resulted in a marked increase in survival (67%) compared to controls (33%).  The time required 
for the CoIIITMPyP-treated surviving mice to right themselves from a supine position was also
significantly decreased (9(±2) min.) compared to the controls (33(±2) min.).  The formation of 
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CoIIITMPyP(CN)2 at pH 7.4 has been shown to be completely cooperative (H =2) with an
association constant of 2.1 (±0.2)  x 1011.  The kinetics were investigated by stopped-flow
spectrophotometry and revealed a complicated net reaction exhibiting four phases at pH 7.4 
under conditions where cyanide was in excess.  The data suggest molecular HCN (rather than 
CN–) to be the attacking nucleophile around neutrality.  The two slower phases do not seem to be
present when cyanide is not in excess and the other two phases have rates comparable to that 
observed for cobalamin, a known effective cyanide scavenger.  Addition of bovine serum 
albumin (BSA) did not affect the cooperativity of cyanide binding to CoIIITMPyP, only lowered
the equilibrium constant slightly to 1.2 (±0.2) x 1011 and had an insignificant effect on the
observed rate.  All observations were consistent with the demonstrated antidotal activity of 
CoIIITMPyP operating through a cyanide binding (i.e., scavenging) mechanism.
3.2 INTRODUCTION 
Cases of cyanide poisoning in which successful clinical intervention was possible have 
frequently involved very high doses of cyanogenic material (multiples of the LD50) being slowly 
absorbed and distributed systemically.  The antidotal use of cyanide-scavenging agents is an 
effective part of the therapy in such cases.31,61,62  While only recently approved for use in the
U.S., cobalamin (i.e., hydroxocobalamin, a vitamin B12 derivative) has been accepted to be a safe 
and effective cyanide antidote for some years in Europe, with the central cobaltIII ion directly
binding cyanide anion.  Cobalamin is, however, a less than ideal cyanide antidote requiring 
intravenous administration in gram quantities.31 Its immediate biological precursor, cobinamide,
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presently under development, is three to ten times more efficacious in vivo.35,63 Unfortunately,
from the pharmaceutical perspective, both of these cyanide scavengers are complicated 
molecules, costly to produce, cobinamide significantly more so than cobalamin.  The alternative 
sodium nitrite-thiosulfate combination therapy is more cost effective, but there are toxicity issues 
beginning to emerge in relation to this treatment.20,29  It follows that there remains a need to find
improved cyanide antidotes that can be produced at reasonable cost and, ideally, stored at 
ambient temperatures. 
Both cobalamin and cobinamide contain cobaltIII chelated within the same macrocyclic
corrin-ring structure, but cobinamide lacks the 5,6-dimethylbenzimidazole ribonucleotide tail 
normally occupying the fifth ligand position in cobalamin.  Clearly, it is advantageous that each 
cobinamide molecule has two axial coordination sites at the cobaltIII ion available to bind two
cyanide anions compared with only one by cobalamin.  Based upon this observation, it is 
reasonable to assert that cobaltIII complexes of other more easily synthesized macrocycles, like
certain porphyrins and phthalocyanines, should exhibit cyanide-binding properties suitable for 
their application to antidotal cyanide scavenging.  Consequently, the results of an earlier study54
showing cobaltIII porphyrins to be ineffective as cyanide antidotes when given to mice
prophylactically are surprising. 
Hypothesizing that there may be one or more pathways through which the putative 
antidote could become slowly deactivated in vivo, an investigation was undertaken into the 
possible therapeutic use of a water-soluble cobaltIII-containing porphyrin as cyanide-scavenging
antidote when given after the toxin.  CobaltIII meso-tetra(4-N-methylpyridyl) (CoIIITMPyP,
Figure 7A, insert) can be synthesized in three steps from commercially available starting 
materials in reasonable yield.  CoIIITMPyP is monomeric over a wide range of pH49 and thus, has
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the required two axial ligand positions available to bind cyanide anions.  The results of this 
dissertation show that the association and rate constants for cyanide binding by CoIIITMPyP are
such that this macrocyclic compound appears to be a suitable candidate for use as a cyanide 
scavenger, together with proof-of-concept data supporting its efficaciousness in mice. 
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Small aliquots of sodium cyanide solution in 5 mM sodium tetraborate buffer (pH 11) were titrated into a 
solution of CoIIITMPyP(OH)(H2O) (A) Electronic absorption spectra of Co
IIITMPyP(OH)(H2O) species
titrated with NaCN, 1.00 cm pathlength.  Main panel:  Initial CoIIITMPyP(OH)(H2O) (dotted trace);
subsequent absorbance changes observed during the addition of cyanide to concentrations of 5, 10, and 15 
µM (solid traces); final spectrum of CoIIITMPyP(CN)2 (dashed trace) after addition of cyanide to 100 μM.
Inset: Structure of CoIIITMPyP.  (B)  Titration of 3.48 μM CoIIITMPyP(OH)(H2O) with cyanide following
the absorbance changes at 454 nm.  The solid line represents a nonlinear least squares fit to the data using 
the Hill equation.  (C) Scatchard plot (number of cyanide molecules bound per CoIIITMPyP(OH)(H2O)
molecule (ν) versus ν/cyanide concentration) of the data from B. 
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Figure 7: Titrations of CoIIITMPyP(OH)(H2O) with cyanide at pH 7.4 and 25°C. 
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3.3 RESULTS 
Binding of cyanide to CoIIITMPyP at physiological pH:  In aqueous media at pH 7.4, 
CoIIITMPyP axially binds two water molecules, one of which is deprotonated to form
CoIIITMPyP(OH)(H2O) with a pKa1 of 6.
51  The second deprotonation occurs at a much higher
pH (pKa2= 10.0) and, therefore, at the physiological pH of 7.4, the aquo/hydroxo form of 
CoIIITMPyP predominates (95%).  Previous work also established that one molecule of
CoIIITMPyP binds two molecules of cyanide.51  The formation of the bis(cyano) adduct occurs in
a stepwise fashion, characterized by the following equations: 
(1) Co-TMPyP(OH)( H2O) + HCN    Co-TMPyP(H2O)(CN) + H2O
    Kf1  
(2) Co-TMPyP(H2O)(CN) + HCN   Co-TMPyP(CN)2 + H3O
+         Kf2
Hambright and Langley52 report an equilibrium constant for the second process (Kf2, 
monocyano to dicyano) to be about 5.6 (± 0.3) x 107.  The equilibrium process in this and many 
other CoIII macrocycles is thought to be completely cooperative, that is the second cyanide
binds as soon as the first is attached to the cobalt atom.  In order to obtain the overall 
equilibrium constant for the binding of two cyanides at physiological pH, a titration of 
CoIIITMPyP(OH)(H2O) with cyanide in 50 mM phosphate buffer, 1 mM EDTA, pH 7.4, was 
carried out using a spectrophotometric method.  CoIIITMPyP(OH)(H2O) in a sealed cuvette
with little to no headspace was monitored spectrophotometically as known amounts of cyanide 
(kept in borate buffer to prevent HCN loss) were added using a gas tight syringe and a time 
interval of 10 minutes was allowed between additions for the solution to equilibrate before 
recording spectra (see Chapter 2.4.2).  The electronic absorption spectra obtained during the 
titration of CoIIITMPyP(OH)(H2O) with cyanide at 25°C display well-maintained isosbestic
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points (Figure 7A) indicating the presence of only two species: the aquo/hydroxo  and the 
dicyano species.  As the wish was to report a physiologically relevant reaction, an effective 
formation constant (K’) can be defined as K’ = [Co
IIITMPyP(CN)2] /([Co
IIITMPyP(H2O)2]
[HCN]2) at pH 7.4 where the hydrogen ion concentration is ignored.  A
further complication arises from the fact that cyanide has a pKa of 9.2 at 25°C, so that 94% of the 
cyanide free in solution is protonated, but the form bound to CoIIITMPyP is the anion. From the 
spectra (at 454 nm) the fraction of the CoIIITMPyP(CN)2 per total porphyrin
(fractional saturation, Y) was determined, and thus the free cyanide concentration (protonated 
and unprotonated) could be calculated.  In Figure 7B the free cyanide is plotted versus the 
fractional saturation (Y) and the data was fit using a nonlinear regression and the Hill equation: 
Y= [(CN)H/K’]/[1+(L)H/K’] 
Using H = 2 gave the best fits of the data (H = 1 is shown for comparison) confirming 
the complete cooperativity of the binding and K’ was found to be 2.1(±0.2) x 10
11.  A
Scatchard plot (Figure 7C) of the data also shows the cooperative nature of the interaction by 
the convex-curve shape obtained.  If independent, non-interacting sites of cyanide binding 
existed, the Scatchard plot obtained would be linear.  Thus the data in Figure 1 confirms the all 
or none reaction of CoIIITMPyP(H2O)(OH) with cyanide to form the dicyano complex as has
been noted for many other water soluble porphyrin and corrin systems. The same calculations 
were applied to the data obtained at 37°C resulting in a K’37°C of 2.4(±0.2) x 10
11.
Kinetics of cyanide binding to CoIIITMPyP:  The substantial magnitude of the 
equilibrium binding constant of CoIIITMPyP to cyanide hints at its potential as a cyanide-
chelating antidote.  To be efficacious, it is also necessary that the reaction of CoIIITMPyP with
cyanide is reasonably fast.  In order to verify the suitably fast binding of cyanide to 
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CoIIITMPyP(OH)(H2O), stopped-flow spectrophotometric experiments were conducted under
pseudo-first order cyanide conditions (at least a 20-fold excess of total cyanide, CN– + HCN),
monitoring the appearance of the CoIIITMPyP(CN)2 Soret maximum (454 nm) at two
temperatures.  At pH 7.4 and 25°C, the resulting data clearly did not represent a single process 
and was best fit by at least three exponentials (Figure 8A).  It was apparent from the sum of the 
amplitudes of these three phases that the overall process was incomplete and, consequently, there 
must be at least one additional slower phase.  The additional phase was inconveniently slow for 
measurement in the stopped-flow spectrometer, so these measurements were performed 
independently in a conventional spectrophotometer.  At both 25°C and 37°C four rate constants 
were obtained that all showed a linear dependence on cyanide concentration with zero or near-
zero intercepts (Figures 8B, 8C, 8D and 8E).  As expected all four rate constants increased upon 
raising the temperature from 25°C to 37°C (Table 1).  The amplitude of the absorbance changes 
was, however, increased for k1 and decreased for k2, while k3 and k4 remained roughly constant 
(Table 1). 
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Figure 8: Kinetics of the reaction of cyanide with CoIIITMPyP(OH)(H2O) under 
pseudo first order conditions. 
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The reaction of sodium azide with CoIIITMPyP(OH)(H2O) was also examined (pH 7.4,
25C) and only one exponential was observed (Figure 9, main panel) apparently in keeping with 
the results of an earlier study involving thiocyanate anion and this same metalloporphyrin.51
From the slope of the linear fit of the observed rates with the azide concentrations (Figure 9, 
insert) a rate constant of 16.2 (±0.8) M-1s-1 (based on total cyanide) was calculated.  This is less
than the previously reported53 value of ~102 M-1s-1 for the rate constant for the reaction of
thiocyanate with CoIIITMPyP(OH)(H2O) at pH 8 (presumably at room temperature) and
intermediate between the k2 (29 M
-1 s-1) and k3 (9 M
-1 s-1) found here for the reaction of cyanide
with CoIIITMPyP(OH)(H2O) at pH 7.4 and 25C (Table 1).  The observed monophasic azide-
binding (Figure 9) and similar thiocyanate-binding53 kinetics strongly suggest that the
multiphasic nature of the cyanide-binding reaction (Figure 8A) is specific to the HCN/CN–
system rather than the metalloporphyrin.  The previous observations of multiphasic kinetic 
behavior for the analogous cobinamide reaction by Baldwin et al.64 support this assertion.  It has
previously been noted65,66 that the available data regarding anion binding to metalloporphyrins
suggests a dissociative mechanism; specifically in the present context, it is the dissociation of 
water molecules that is expected to be rate limiting and the identity of the incoming nucleophile 
should be relatively unimportant in determining the substitution rate.  Therefore, the similarity of 
the rate constants found for the reaction of CoIIITMPyP with N3
–, cyanide, and that previously
reported for SCN– is53 i) unremarkable and ii) does not provide any unambiguous clues as to
whether HCN or CN– might be the attacking species in any of the phases documented in Table 1.
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Table 1: Second order rate constants and absorbance amplitudes for the formation of 
CoIIITMPyP(CN)2 at 25-37°C, pH 7.4-8.4 in 0.1 M sodium phosphate buffers.
Conditions 
Phase 1 Phase 2 Phase 3 Phase 4 
k1 (M
-1s-1) A% k2 (M
-1s-1) A% k3 (M
-1s-1) A% k4 (M
-1s-1) A% 
pH 7.4, 25 C 111 (±7) 6 29 (±1) 40 9 (±1) 8 0.35 (±.05) 46 
pH 7.4, 37 C 270 (±24) 14 93 (±9) 25 20 (±3) 7 0.7 (±.05) 49 
pH 8.4, 25 C ----- 0 30 (±5) 9 5 (±1) 18 0.4 (±.05) 43 
The observed kinetics could be resolved into four exponential phases.  Rate constants are calculated from 
linear fits of observed rates to the cyanide concentration as shown in Figure 8 (cyanide was in at least 20-
fold excess over porphyrin).  The percent absorbance change (amplitude) for each phase is also given. 
Uncertainties shown in parentheses are standard deviations. 
Seeking clarification regarding the possible involvement of HCN and/or CN–, the kinetics
of cyanide binding at pH 8.4, where the porphyrin is still expected to be predominately (> 95%) 
in the aquo/hydroxo form (pKas = 6.0 and 10.0)
53 were examined.  At pH 8.4, in 50 mM
phosphate buffer, only two exponential phases were revealed in the stopped-flow data (not 
shown) plus the slowest phase observed by conventional spectrophotometry remained.  The 
fastest rate, k1, could no longer be found and the slower rate constants were essentially 
unchanged (Table 1).  As the fast rate, corresponding to k1 (Figure 8B) may have increased and 
been lost in the dead-time, the kinetics were carefully examined at lower cyanide concentrations, 
on a millisecond time scale, and even at a temperature of 10C in an attempt to observe the 
“missing” phase.  It was found that the total absorbance changes were very similar to those 
observed at pH 7.4 (except slower-corresponding to the second rate constant) and thus our 
conclusion is that the “fast” rate, with rate constant k1, is not present at pH 8.4.
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The reaction was followed at 454 nm in 50 mM potassium phosphate buffer, pH 7.4, 1 mM EDTA, 25C 
under conditions of excess sodium azide (500 to 5000 µM).  Main panel: Representative stopped flow 
kinetic transient for the reaction of azide with CoIIITMPyP(OH)(H2O) under pseudo first order conditions
(solid circle) with a single exponential fit (solid line). Inset: Linear fit of the observed rates with increasing 
azide concentration, slope = 16.2(±0.8) M-1s-1. 
Cyanide binding to CoIIITMPyP in the presence of bovine serum albumin (BSA):  In 
vivo CoIIITMPyP will encounter many biomolecules potentially able to interfere with its cyanide-
scavenging capability.  Serum albumin is present at relatively high concentration in the 
bloodstream and thus a likely participant in such interference.  Therefore, examination of the 
reaction of CoIIITMPyP with cyanide in the presence of a physiologically relevant amount of
bovine serum albumin (10 M BSA) should be instructive.  In the presence of BSA the 
electronic absorption spectra of both CoIIITMPyP(OH)(H2O) and Co
IIITMPyP(CN)2 (Figures
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Figure 9: Kinetics of the reaction of azide with CoIIITMPyP(OH)(H2O) under pseudo first order
conditions. 
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10A and B) exhibited very minor differences (red shifts and decreases in intensity) compared 
with the spectra of the same species in BSA-free buffer.  BSA is a cysteine-rich protein and it is 
reasonable to expect more dramatic spectral changes than those evident (Figures 10A and B) if 
substantial displacement of the water-derived axial ligands in CoIIITMPyP(OH)(H2O) by
cysteine thiols occurred.  The small shifts and intensity differences observed most probably 
indicate an interaction between BSA and the metalloporphyrin primarily involving the 
macrocyclic moiety rather than the cobaltIII ion.  A titration experiment was then conducted to
assess any effect of the presence of BSA on cooperativity and binding equilibrium in the reaction 
of cyanide with CoIIITMPyP.  The titration curve (fractional saturation versus free cyanide,
Figure 10C) indicated that the cooperativity of the cyanide binding was essentially maintained 
and the equilibrium was only slightly lowered; K’BSA = 1.2 (±0.2) x 10
11 at 25°C.  Additionally,
when the rate of cyanide binding in the presence and absence of BSA was conducted, it was clear 
that the initial rates were virtually identical (Figure 10D).  So, contrary to expectation, these 
observations collectively suggest that the presence of proteinaceous species (such as amines or 
thiols) as potential axial ligands does not, in fact, interfere significantly with the cyanide-
scavenging ability of CoIIITMPyP.
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(A) Electronic absorption spectra from 400 nm to 500 nm of 3.48 μM CoIIITMPyP(OH)(H2O) (solid trace),
CoIIITMPyP(OH)(H2O) + 10 μM BSA (dotted trace).  (B) Electronic absorption spectra from 500 nm to 700
nm of 3.48 µM CoIIITMPyP(CN)2 (solid trace) and Co
IIITMPyP(CN)2 + 10 μM BSA in the presence of excess
cyanide (dash-dot trace).  (C) Small aliquots of sodium cyanide solution in 5 mM sodium tetraborate buffer 
(pH 11) were titrated into a solution of CoIIITMPyP(OH)(H2O) (3.48 µM in 50 mM sodium phosphate buffer,
pH 7.4, 1 mM in EDTA) in the presence of 10 μM BSA using gas-tight syringes and a 1.00 cm pathlength 
septum-sealed cuvette at 25C (see Chapter 2.4.2 for further details).  The solid line represents a nonlinear 
least squares fit to the data using the Hill equation.  (D) The rate of cyanide binding in the presence (solid 
dots) and absence (solid trace) of BSA. Conditions: 3.48 µM CoIIITMPyP(OH)(H2O) in 50 mM sodium
phosphate buffer, pH 7.4, 1 mM in EDTA and 0.1 mM in NaCN. 
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Figure 10: Titrations and kinetics of CoIIITMPyP(OH)(H2O) with cyanide in the presence of BSA at
pH 7.4 and 25°C. 
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Animal Experiments:  A previous study with mice in which CoIIITMPyP was given as a
prophylactic, 15 and 60 minutes prior to the administration of lethal doses of cyanide, found no 
beneficial antidotal effect.54 To the contrary, in the present work with Swiss Webster mice
(males, 16-20 weeks of age) the effectiveness of CoIIITMPyP as a cyanide antidote when
administered after the toxin (Figure 11) was demonstrated.  These data require some comments 
for clarification.  The LD50 for NaCN given i.p. to the same kind of mice as employed in this 
work has been reported to be 5.7 mg/kg by Baskin et al.67  Clearly, since 12 out of 18 control
mice died (Figure 11A) the 5.0 mg/kg NaCN used in the present experiments was greater than 
the LD50.  The reason for the discrepancy probably resides in the ease with which volatile HCN 
can be lost from working cyanide solutions.  Despite attempting to reduce these losses by 
working in sealed vessels with minimized headspaces and making all transfers with gas-tight 
syringes, in our laboratory the effective LD50 for i.p. NaCN has appeared to vary between the 
reported 5.7 mg/kg and about 4.5 mg/kg – dependent upon the particular combinations of 
glassware and personnel employed.  Given the likely systematic error involved (HCN loss) 
during manipulations, it is our opinion that the true value for the LD50 for i.p. NaCN must lie 
closer to 4.5 mg/kg than 5.7 mg/kg for these mice.  For descriptive purposes, the current 5.0 
mg/kg NaCN dose is labeled as “just lethal.”  When CoIIITMPyP (21 mg/kg, i.p.) was
administered within 1 minute of this cyanide dose, survival increased from 33% to 67% (Figure 
11A).  Recently, 85% survival for mice given 12 mg/kg sodium nitrite as an antidote 2 min. after 
the same just-lethal NaCN dose20 was observed.  The ability of surviving intoxicated individuals
placed upon their backs to right themselves (see Chapter 2.4.4) is a convenient behavioral 
assessment of sub-lethal intoxication and recovery.  The ability of surviving mice to right 
40 
themselves was found to be significantly improved by administration of CoIIITMPyP compared
to controls given just saline, with recovery times the same as those previously found for sodium 
nitrite20 being observed (Figure 11B).  In summary, when given shortly after the toxin,
CoIIITMPyP is clearly antidotal to cyanide intoxication in mice.
 
(A) Survival rates showing the efficacy of CoIIITMPyP (20.8 mg/kg, 20% LD50, i.p.) and sodium nitrite  (12
mg/kg, i.p.) in Swiss-Webster mice (males, 16-20 weeks of age) given a just-lethal dose of  NaCN (5 
mg/kg i.p.).  Following the administration of toxin (t = 0) the antidote was quickly delivered (CoIIITMPyP 
at t = 1 min, or sodium nitrite at 2 min, both i.p.).  (B) The righting recovery time of the surviving cyanide-
intoxicated mice was decreased in those administered CoIIITMPyP (20.8 mg/kg) or sodium nitrite (12 
mg/kg, i.p.).  Following the administration of toxin (t = 0) and antidote, the surviving mice were placed on 
their backs and the times at which the animals righted were recorded (see Chapter 2.4.4 for details). 
3.4 DISCUSSION 
Antidotal effectiveness of CoIIITMPyP:  Equilibrium constants for the binding of 
cyanide to various cobaltic macrocycles have been reported, but the numerical values depend on 
assumptions made about the binding model –in particular, i) whether [CN–] or [HCN] is written
on the left hand side of equations 1 & 2 and ii) should the hydrogen-ion concentration be 
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Figure 11: The antidotal effect of CoIIITMPyP on cyanide-intoxicated mice. 
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included.54,68-72  For example, the formation constant for the (mono)cyano adduct of the FDA
approved cyanide-scavenging agent cobalamin (or vitamin B12) was originally (1960) evaluated 
in terms of a model assuming CN– to be the incoming nucleophile:72
(3) B12(H2O) + CN
–  B12(CN
–) + H2O;      Kf{1960} = [B12(CN
–)] / ([B12(H2O)][CN
–]) ≈ 108
In a seminal paper almost 20 years later (1979) Reenstra and Jencks69 showed, however, that
HCN is the relevant nucleophile around neutrality: 
(4) B12(H2O) + HCN  B12(CN
–) + H3O
+;  Kf{1979} = [B12(CN
–)][H3O
+] / ([B12(H2O)][HCN])
Here, in the case of CoIIITMPyP, it is agreed upon that two cyanide molecules displace the
water-derived axial ligands from the aquo/hydroxo form of CoIIITMPyP, but make no other
assertion as to the species of cyanide (HCN or CN–) involved, or whether a proton is
consumed/released.  That is, to facilitate comparison with ligand-binding constants as normally 
reported for metalloproteins, an essentially biochemical convention is adopted and the result as 
K’ with a value of 2.1(±0.2) x 10
11 is presented, where the equilibrium constant has been
evaluated in terms of total cyanide (= [HCN + CN–] ≈ [HCN] at pH 7.4) and the product [H3O
+]
has simply been left out.  Consequently, to meaningfully compare the present result with the 
earlier formation constant for cyanocobalamin of George et al.,72 the earlier result should be
multipied by [CN–]/[HCN] at neutrality:  108 x (~10-2) ≈ 106.  Therefore, inspection of the
relevant equilibrium constants suggests that CoIIITMPyP could be a significantly better cyanide
scavenger than cobalamin. 
Hambright et al. have reported52 a formation constant of 5.6 x 107 for the binding of a
second cyanide anion to the monocyanoCoIIITMPyP complex.  Re-calculating this result to
reflect total cyanide rather than the anion concentration (as per the earlier authors) gives K’f2 = 
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9.0 x 105, again a significantly smaller numerical value, confirming that some care needs to be
exercised in comparing results from different studies.  It follows that Kf1 = K’ – K’f2 = 2.1 x 
1011 – 9.0 x 105 ≈ 105.  These estimates for the two formation constants (i.e., Kf1 and K’f2 ≈ 10
5
and 106 respectively) are in keeping with the binding of cyanide to CoIIITMPyP being
cooperative and, indeed, a Hill constant of 2.0 fits the equilibrium data much better than a 
constant of 1.0 (Figure 7B) or any intermediate number.  Titrations performed in the presence of 
one equivalent BSA (Figure 10C), a possible source of interference in serum, show no alteration 
in the cooperativity of cyanide binding to CoIIITMPyP and only modest changes in the
equilibrium constant (1.2 x 1011 in the presence of BSA vs. 2.1 x 1011 without).  Moreover, a
kinetic comparison (Figure 10D) shows that there is virtually no difference in the rate of cyanide 
binding to CoIIITMPyP in the presence and absence of BSA.  These findings appear to confirm
the promising candidacy of CoIIITMPyP as a potentially useful cyanide antidote.
The second order rate constant for the binding of cyanide to cobalamin at 25ºC and 
approximately neutral pH has been reported to be 80 M-1s-1.69  This is comparable to the faster
phases of the reaction observed for cyanide with CoIIITMPyP (Table 1).  Therefore, there does
not seem to be any overriding kinetic reason why CoIIITMPyP should not, by virtue of its
cyanide-scavenging ability, have reasonable antidotal activity toward cyanide intoxication.  
Consequently, the reported54 lack of any such antidotal activity in mice is troublesome, as based
upon these findings the accepted cyanide-scavenging mechanism by which cobalamin surely 
works could logically be questioned. 
In the previous study54 the CoIIITMPyP (and other metalloporphyrins) were given
prophylactically, 15 and 60 min. before the (lethal) cyanide dose, with no detectable beneficial 
effect.  In the present proof-of-concept study the CoIIITMPyP was delivered soon (1 min.) after
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the cyanide and found readily measurable protection both in terms of fewer deaths (Figure 11A) 
and quicker recovery of survivors (Figure 11B) for mice given the antidote compared to controls.  
The failure of CoIIITMPyP as a prophylactic cyanide antidote must be due to its inactivation
within 1-15 min. in vivo.  The possible mechanism(s) responsible for this inactivation are 
currently under investigation and will be presented in due course. 
Complexity of the reaction between CoIIITMPyP and cyanide:  The kinetics and 
mechanisms of the substitution reactions of various anionic ligands with water-soluble 
porphyrins have been studied by several groups, but in particular, Pasternack & Cobb53 found
that the addition of thiocyanate (SCN–) and a solvent proton to CoIIITMPyP(OH)(H2O) resulted
in an intermediate, CoIIITMPyP(H2O)(SCN), which then quite rapidly acquired a second
thiocyanate ion to form CoIIITMPyP(SCN)2.  The presence of the thiocyanate group was found to
exert a trans influence in the CoIIITMPyP(H2O)(SCN) intermediate resulting in the fast addition
of the second  thiocyanate, so that the addition of the first thiocyanate is the rate-determining 
step.  The limited data set obtained for the reaction of CoIIITMPyP with azide (N3
–) (Figure 9)
appears to be in keeping with an analogous mechanism.  Based upon such observations, it is 
reasonable to expect that cyanide should behave similarly and, indeed, in the case of another 
water-soluble metalloporphyrin, CobaltIII-tetrakis(4-sulfonatophenyl)porphyrin (CoIIITSPP), a
two-step reaction in which the first step is rate limiting was found.52  In their report primarily on
the CoIIITSPP-cyanide reaction, Hambright and Langley52 briefly noted that the first cyanide
addition to CoIIITMPyP(OH)(H2O) had a rate constant of 1.1 x 10
3 M-1s-1 at pH 7.4 and 25°C –
but then made no further mention of CoIIITMPyP, did not show any of the relevant data and their
opinion regarding the attacking species, cyanide anion or HCN, was unclear.
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As is now shown, the kinetics of cyanide binding to CoIIITMPyP are remarkably
complicated with three to four rate constants (depending on pH, see Table 1) all of which depend 
on the cyanide concentration (Figure 8).  It is highly unlikely that unidentified impurities in the 
CoIIITMPyP preparations are responsible for any of these phases as the otherwise analogous
azide reaction exhibits only a single phase (Figure 9).  Similar, Baldwin et al.64 observed three
exponential phases in their study of the rate of reaction of cyanide with cobinamide, a CoIII-
containing corrin, where the fastest phase was lost on raising the pH from 7 to 8.  Therefore, the 
observed kinetics of the association reaction between cyanide and CoIIITMPyP (Figure 8, Table
1) has more features in common with the analogous cobinamide reaction64 than with the
CoIIITSPP reaction.52  The pKa of HCN is 9.24 at 25ºC
73 and it follows that in the kinetic
experiments at pH 8.4 the concentration of cyanide anion was an order of magnitude greater than 
at pH 7.4.  Therefore, if CN– were the incoming nucleophile in any of the kinetic phases, there
should be a significant increase in the observed rate for that phase at pH 8.4 compared to pH 7.4.  
No such effect was observed and, consequently, the data indicate molecular HCN to be the more 
important attacking nucleophile.  This is in keeping with the previously reported findings for 
cobalamin where HCN was also shown to be the attacking nucleophilic species around neutral 
pH rather than the anion.69  To the contrary, the reaction of cyanide with CoIIITSPP does appear
to involve both HCN and CN– under neutral conditions, as the observed reaction rate increases
by 30% between pH ~7 and ~8.52  At pH 7.4, a small portion of CoIIITMPyP (~4%, pKa = 6)
exists as the diaquo complex (CoIIITMPyP(OH2)2) whereas at pH 8.4, a small portion (~ 3%, pKa
= 10) is present as the dihydroxo complex (CoIIITMPyP(OH)2).  In the case of both cobalt
III
corrins64 and porphyrins,52 displacement of the axial aquo ligands in the bis(aquo) complexes by
cyanide is very slow and, consequently, the presence of the rapid phase 1 at pH 7.4 (and its 
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absence at pH 8.4) (Table 1) cannot be explained on the basis of this phase involving reaction of 
the bis(aquo) CoIIITMPyP.
It is apparent in the kinetic traces (e.g., Figure 8A) that the reaction was still continuing 
more than 15 min. after it was initiated.  This was not the case in the titration experiments where 
absorbance changes had ceased within 10 min. of cyanide additions being made and suggests 
that at least the phase associated with k4 (and perhaps also that associated with k3) is(are) only 
present when cyanide is in large (> 20-fold) excess over CoIIITMPyP.  There are plausible
explanations for such behavior.  For example, cyanide may self-associate to form complex 
species (such as NC—H---NCH, [NC—H---NC]–, etc.) that could form metastable complexes
with CoIIITMPyP, inhibiting its final conversion to CoIIITMPyP(CN)2.  Supporting this
argument, the amplitude of phase 4 was observed to diminish at high ionic strength (0.3 M KCl, 
not shown).  Since the focus of the present study was, however, the potential use of CoIIITMPyP
as an antidotal cyanide scavenger, the details of reactions in which cyanide is in large excess are 
of marginal interest and investigation of the slow phases was abandoned. 
Resultantly, the two quicker phases must be considered in relation to cyanide scavenging 
in vivo, where the cyanide cannot be in large excess over the antidote if the intervention is to be 
successful.  The kinetics of the reaction between pyridine and CoIIITMPyP have previously been
shown to be biphasic at pH 8 and explained on the basis of rapid substitution by the first pyridine 
followed by slower substitution of the second to yield the bis(pyridyl) product.50  The cyanide
results, monitored at the absorption maximum for CoIIITMPyP(CN)2 (454 nm), are inconsistent
with a similar biphasic mechanism at pH 8.4.  If phase 2 were to represent formation of the 
mono(cyano) adduct followed by phase 3 leading to the final bis(cyano) product, then the 
amplitude of phase 3 would have to be the same or greater than the phase 2 amplitude, whereas 
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the reverse situation was actually observed (Table 1).  The amplitudes of phase 2 and phase 4 
(Table 1) are consistent with a two-step mechanism similar to the pyridine reaction, but if this 
were the case, phase 4 would have to dominate the later stages of any titration procedures rather 
than be absent as already stated.  Based upon these observations, it is concluded that the presence 
of more than one independent phase in the cyanide-reaction kinetics necessarily means there are 
multiple mechanistic pathways to product formation and suggest the following scheme (Figure 
12) to account for the two faster processes (Phases 1 and 2):
47 
Figure 12: A plausible scheme for the two fastest phases of the reaction between CoIIITMPyP and 
HCN at pH 7.4-8.4. 
The key features of this scheme are i) interconversion of liganded HCN and CN– in the
intermediate, with an associated pKa somewhat less than 7.4, accounts for the absence of phase 1 
under mildly alkaline conditions (Table 1) and ii) the differing trans effects of HCN and CN–
account for the two distinct rate constants (k1 and k2).  Of course, our assertion that HCN is the 
most important attacking nucleophile only applies to the experimentally detected rate-
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determining processes.  For reasons discussed above, these findings cannot be reconciled with 
the substitution of the first cyanide being rate limiting in the reaction with CoIIITMPyP.
Consequently, in the initial fast step leading to formation of the mono(cyano) intermediate, the 
nucleophile could be CN– rather than HCN (as drawn) or a combination of both.
Concluding Remarks:  However perplexing the mechanistic details may be, the rate of 
the cyanide reaction with CoIIITMPyP and the magnitude of the association constant are large
enough to render this metalloporphyrin an effective antidote to cyanide intoxication in 
experimental animals (Figure 11).  The multiple positive charges on the molecule (Figure 7A, 
inset) lead us to suspect that it may partition into mitochondria and have an undesirable toxicity 
not readily apparent in the present proof-of-concept study.  Nevertheless, the results are 
encouraging in so far as they suggest that many cobaltic macrocycles should be antidotal to 
cyanide intoxication, broadening the range of potential candidate structures to include simpler, 
less expensive molecules than the corrinoids currently either available, or under development.
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4.0  THE EFFECT OF ASCORBATE ON THE CYANIDE 
SCAVENGING CAPABILITY OF CoIIITMPyP
4.1 ABSTRACT 
The rate of reduction of CoIIITMPyP by ascorbate is quite rapid, with second order rate
constants of 8.3 x 104 M-1s-1 at 25°C and 1.4 x 105 M-1s-1 at 37°C.  Addition of cyanide to
CoIITMPyP results in the binding of cyanide as evidenced by EPR spectroscopy but CV and
kinetic investigations indicate that cyanide induces oxidation to the CoIII dicyano species.   The
equilibrium binding constant derived from the addition of cyanide to the reduced form (K = 2.1 
(±0.1) x 1010) is quite similar to the previously determined binding constant for cyanide binding
to the oxidized form (CoIIITMPyP, K = 2 x 10
11).   EPR spectra of mouse blood taken after the
addition of the CoIIITMPYP show that the cobalt is reduced and that subsequent addition of
cyanide to the blood results in the disappearance of this signal indicating that cyanide scavenging 
has taken place.  The kinetics of cyanide binding to CoIITMPyP are complicated; four phases
were found, which were shown to be dependent on the cyanide concentration.  A mechanism for 
the binding of cyanide to the reduced form is proposed. 
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4.2 INTRODUCTION 
In a recent proof-of-concept study the efficacy of CobaltIII meso-tetra(4-N-
methylpyridyl)porphine (CoIIITMPyP) as an antidote for cyanide toxicity (Chapter 3) was
demonstrated.  Therefore, the results of an earlier investigation54 showing cobaltIII porphyrins to
be ineffective as cyanide antidotes when given to mice prophylactically remain intriguing.  
While some effort was expended on CoIIITMPyP and other water-soluble cobalt porphyrins in
the past,49, 52-54 there seems to be no recent work addressing the possible development of these
compounds as cyanide scavengers.  This is surprising given the renewed interest in the 
availability of such compounds to treat victims of smoke inhalation.74-76 As such, further effort
was expended in pursuit of finding cyanide-binding agents that are cheaper and similarly 
effective to the known compounds hydroxocobalamin and cobinamide.  Hypothesizing that the 
reported lack of prophylaxis exhibited by CoIIITMPyP in cyanide-intoxicated mice54 might be a
consequence of the reduction of the complex to the CoII form by reductants circulating in the
blood, the following has been undertaken in this chapter:  (i) an investigation into the kinetics of 
reduction of CoIIITMPyP by ascorbate; (ii) a determination of the equilibrium and kinetic
cyanide-binding characteristics of the reduced product, CoIITMPyP; (iii) verification that the
same reactions occur in the mouse bloodstream. 
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4.3 RESULTS 
Ascorbate reduction of CoIIITMPyP: The reduction of CoIIITMPyP to CoIITMPyP has
been shown to have a quasi-reversible reduction potential with an E0’ of 0.42 V in 0.1 M H2SO4
vs. NHE using either cyclic voltammetry (CV) or by spectroelectrochemistry employing an 
optically-transparent thin-layer electrode (OTTLE) in the absence of oxygen.77,78  Pasternack and
Cobb,51 verified by Chan et al.,77 determined CoIIITMPyP to have two pKas of  6.0 (±0.1) and
10.0 (±0.1) for the following acid-base equilibria: 
(5) CoIIITMPyP(H2O)2  Co
IIITMPyP(H2O)(OH) + H
+ Ka1  
(6) CoIIITMPyP(H2O)(OH) Co
IIITMPyP(OH)2 + H
+       Ka2 
Thus at neutral pH, the aquo/hydroxo form predominates and the pertinent equation for reduction 
at pH > 6, as determined by Chan et al., is as follows: 
CoIIITMPyP(H2O)(OH) + e
- + H+    CoIITMPyP
The absence of axial ligands in the product should be taken to mean that the presence of either 
one, two or no water molecules is somewhat controversial, although Stich et al. have concluded 
that there are no axial ligands present in reduced corrinoids.79 Chan et al. also determined the
reduction potential at pH 7.4 to be 0.33 V vs. NHE.  The product of the reaction was previously 
determined by exhaustive electroreduction of CoIITMPyP in an OTTLE cell.77  Ascorbate, found
in circulating plasma at a concentration of ~60 M,80 has a reduction potential of -0.0681 and
therefore should easily be able to reduce CoIIITMPyP(OH)(H2O).  The rate of reduction under
pseudo-first order conditions was observed by stopped-flow spectrophotometry by following the 
disappearance of the 440 nm band of CoIIITMPyP(OH)(H2O).  Linear fits of the observed rates to
sodium ascorbate concentrations were used to determine a rate constant of 8.3 x 104 M-1s-1 at
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25°C and 1.4 x 105 M-1s-1 at 37°C (Figure 13).  So, given that the level of ascorbate in mouse
blood is ~60 M and the effective antidotal dose of CoIIITMPyP should lead to approximate
blood concentrations of ~200 M soon after injection, the anticipated initial rate of 
CoIIITMPyP(OH)(H2O) reduction is given by 1.4 x 10
5 M-1s-1 x (60 x 10-6) x (200 x 10-6) = 1.7 x
10-3 M/s.  That is, the antidote will become reduced to its CoII form essentially as it is absorbed
into the bloodstream, any residual CoIIITMPyP(OH)(H2O) is only likely to persist for a matter of
seconds. 
 
The reaction was followed at 427 nm in 50 mM potassium phosphate buffer, pH 7.4, 1 mM EDTA , at 
25C and 37°C under conditions of excess ascorbate (0 to 10 mM). 
Cyclic Voltammogram of CoTMPyP in the presence of cyanide: Mosseri et al.82
observed that after the reduction of CoIIITMPyP by -radiolysis, addition of KCN resulted in the
disproportionation of CoIITMPyP to [CoIIITMPyP(CN)2]
2-, that is the CoIII-phorin species (where
an electron resides on the porphyrin ring).83  Using cyclic voltammetry (CV), Mosseri et al.
found that the addition of excess cyanide to CoIIITMPyP resulted in a more negative reduction
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Figure 13: Kinetics of the reaction of ascorbate with CoIIITMPyP(OH)(H2O) under 
pseudo first order conditions. 
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potential.82   CV performed on CoIIITMPyP in the presence of excess cyanide resulted in a single
ipc at 160 mV, which had no corresponding wave (ipa) during a positive potential scan (Figure 
14A).   Under similar conditions, cobinamide (CoIII-corrin) exhibited a virtually identical CV
with a slightly more negative potential, 125 mV (Figure 14B).  These results suggest that perhaps 
there is an alternative mechanism for the oxidation of CoIITMPyP to CoIIITMPyP in the presence
of cyanide, such as the disproportionation mechanism suggested by Chan et al. in their -
radiation reduction experiments. Certainly, in the case of neither CoTMPyP, nor cobinamide, is 
there any simple reversible CoIII/CoII one-electron redox process in the presence of cyanide.
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Samples of CoIIITMPyP and Cbi(OH)+ (200 μM) were prepared anaerobically in 0.1 M NaNO3, 50 mM
potassium phosphate buffer, pH 7.4, at room temperature, reduced with excess sodium ascorbate (20 mM), 
then excess cyanide (20 mM) was added. 
Electronic paramagnetic resonance studies: Reduction of CoIIITMPyP by ascorbate
results in the CoIITMPyP species exhibiting an x-band electron paramagnetic resonance (EPR)
spectrum84 quite unlike that obtained following subsequent addition of excess cyanide (Figure
15A).  The observed hyperfine results from the interaction of the unpaired electron (Co II = d7)
with the 59Co nucleus (I=7/2) having Aparallel values of 104 gauss (Fig, 15A). For comparison, the
EPR spectrum in the absence of cyanide, has an Aparallel of 96 gauss (in the unliganded reduced 
form).84 These EPR signals were only transiently observed; that is, they were completely absent
in samples maintained at ambient temperature for a minute after the addition of cyanide before 
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Figure 14: Cyclic Voltammograms of CoIIITMPyP(OH)(H2O) and cobinamide with cyanide at pH
7.4 and temperature of 25°C. 
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freezing.   These observations strongly suggest that cyanide binds to the reduced form of 
CoIITMPyP and that the cyanide then catalyzes the oxidation of CoIITMPyP back to its EPR-
silent CoIII form.  Very similar EPR spectral changes have also been observed following cyanide
addition to cobinamide85,86 – indicating an analogous set of reactions.  For comparison, the EPR
spectrum of the reduced CoIITMPyP species in the presence of excess pyridine is shown (Fig.
15B) where three line super hyperfine due to 14N can be observed.  Note that this spectrum is
indicative of a 5-coordinate mono(pyridine) adduct, since a bis(pyridine) structure would be 
expected to exhibit nine-line superhyperfine features.  The lack of superhyperfine coupling in the 
cyanide bound form of CoIITMPyP indicates that the binding of cyanide anion appears to be
through the carbon atom. 
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Figure 15: X-band EPR spectra of ascorbate-reduced CoIITMPyP and mouse blood at 10 K. 
Samples of CoIIITMPyP (1 mM) were prepared anaerobically in 50 mM potassium phosphate buffer, pH 
7.4, at room temperature, reduced with excess sodium ascorbate (20 mM), then excess cyanide (20 mM) 
was added, and rapidly frozen in liquid nitrogen for subsequent recording of spectra.  Samples of mouse 
blood were obtained by heart puncture to which CoIIITMPyP (1 mM) and then excess cyanide (20 mM) was 
added, and rapidly frozen in liquid nitrogen for subsequent recording of spectra.  EPR conditions: 9.8 G 
modulation amplitude, 63.2 μW microwave power, 10 K.  a:  CoIITMPyP-CN.  b: CoIITMPyP-py   c: 
Mouse blood and CoIIITMPyP (1 mM) d:  Sample c with excess cyanide (20 mM)
Mouse blood electron paramagnetic resonance studies:  One way of assessing the 
biological reactions of CoTMPyP after adding it to the blood of mice is by EPR spectroscopy.  
While the absorbance of the normal porphyrin in blood would obscure the absorption spectrum 
of CoTMPyP, the EPR spectrum of the reduced form should be readily observable.  When the 
blood of mice to which CoIIITMPyP had been added was examined, it was determined that a
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portion of the CoTMPyP was reduced (see Fig. 15C) by the appearance of a signal at ~3000 
gauss.  This signal persisted for up to 30 minutes and no signals, which could be associated 
with the oxygen bound form of CoTMPyP were observed.  The EPR signal observed in mouse 
blood had some features in common with the CoIITMPyP(py) species (Fig. 15B); however,
while some hyperfine was visible, no superhyperfine features are apparent.  There is frequently 
“g-strain” associated with the EPR spectra of biological samples – a microvariability in the 
structure of metal-ion sites leading to line broadening and resulting elimination of hyperfine 
structure.  Consequently, the failure to observe any superhyperfine features does not necessarily 
mean the absence of nitrogen donor ligands.  In the blood samples, the added CoIITMPyP is
probably present as a mixture of five-coordinate structures in which the axial ligand is either a 
sulfur donor such as a cysteine thiol, or a nitrogen donor such as a histidine imidazole or a 
lysine amino group.  Addition of an excess of cyanide resulted in the complete disappearance of 
these signals (Figure 15D), consistent with cyanide binding and subsequent oxidation to 
CoIIITMPyP(CN)2.  While an intermediate Co
IITMPyP(CN) complex could not be observed,
this species rapidly oxidizes (see Electron paramagnetic resonance studies) and is difficult to 
trap.   
Cyanide binding to CoIITMPyP:  In order to better understand the reaction of cyanide 
with the reduced porphyrin, CoIITMPyP (prepared by ascorbate reduction) was anaerobically
titrated with cyanide in 50 mM phosphate buffer, 1 mM EDTA, pH=7.4, using a 
spectrophotometric method.  CoIITMPyP in a sealed cuvette with little to no headspace was
monitored spectrophotometrically as known amounts of cyanide (kept in borate buffer to 
prevent HCN loss) were added using a gas tight syringe and a time interval of 10 minutes was 
observed between additions for the solution to equilibrate (see Chapter 2.4.2).  The electronic 
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absorption spectra obtained during of the titration of CoIITMPyP with cyanide at 25°C do not
initially display tightly maintained isosbestic points (Figure 16A).  After the addition of less 
than 1/2 of an equivalent of cyanide, the observed electronic absorption spectrum becomes, 
however, identical to that obtained during titrations starting from the oxidized 
CoIIITMPyP(OH)(H2O) species (Fig. 16A, dashed trace).  The subsequent spectra do maintain
isosbestic points and the final spectrum is that of the CoIIITMPyP(CN)2 complex (Fig. 16A,
dotted trace). Thus a very similar result to Chan et al. was observed, the presence of cyanide 
leads to generation of the oxidized CoIIITMPyP(CN)2 form.  Furthermore, because the reaction
proceeds (to complete oxidation) in the presence of substoichiometric amounts of cyanide 
relative to the metalloporphyrin, it appears that the cyanide has a catalytic action.  As a 
physiologically relevant reaction is desirable, an effective formation constant (K’) can be 
defined as K’ = [Co
IIITMPyP(CN)2] / ([Co
IITMPyP][HCN]2) at pH 7.4 where the hydrogen ion
concentration is ignored.  From the spectra (at 454 nm) the fraction of the CoIIITMPyp(CN)2 per
total porphyrin (fractional saturation, Y) was determined, and thus the free cyanide 
concentration (protonated and unprotonated) could be calculated.  In Figure 16B the free 
cyanide is plotted versus the fractional saturation (Y) and the data was fit using a nonlinear 
regression and the Hill equation: 
 Y= [(CN)H/K’]/[1+(L)H/K’] 
Using H = 2 gave the best fits of the data confirming the cooperativity of the cyanide 
binding and K’ was found to be 2.1 (±0.1) x 10
10 (Figure 16B) very similar to the binding of
cyanide to the oxidized species, CoIIITMPyP(OH)(H2O) (2.1 (±0.2) x 10
11, Chapter 3).
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Figure 16: Titrations of CoIITMPyP with cyanide at pH 7.4 and 25°C. 
Small aliquots of sodium cyanide solution in 5 mM sodium tetraborate buffer (pH 11) were titrated into a 
solution of CoIITMPyP (3.48 µM in 50 mM sodium phosphate buffer, 1 mM EDTA pH 7.4) using gas-tight 
syringes and a 1.00 cm pathlength septum-sealed cuvette at 25°C (see Chapter 2.4.2 for further details). 
(A) Electronic absorption spectra of CoIITMPyP species titrated with NaCN, 1.00 cm pathlength.  (B)  
Titration of 3.48 μM CoIITMPyP with cyanide following the absorbance changes at 454 nm.  The solid line 
represents a nonlinear least squares fit to the data using the Hill equation. 
Rate of reaction of CoIITMPyP with cyanide to form CoIIITMPYP(CN)2:  The
reaction of CoIITMPyP with excess cyanide under pseudo first order conditions was studied at 25
and 37C.  Interestingly, the following reaction phases did not seem to be sensitive to the 
presence or absence of oxygen.  CoIIITMPyP(OH)(H2O) was reduced with an excess of
ascorbate, rapidly mixed with excess cyanide, the reaction was observed at 427 nm (absorption 
maxima of the reduced species) and at 454 nm (absorption maxima of the oxidized dicyano 
species).  The reaction was complicated with four phases, all of which were dependent on the 
cyanide concentration.  The last two phases, with rate constants designated k3 and k4, were found 
to coincide, identically, with the last two phases previously observed for the reaction of cyanide 
with CoIIITMPyP(OH)(H2O) (Chapter 3).  The first two phases (with rate constants designated as
k1 and k2, shown in Table 2) were both dependent upon cyanide concentration at 25 and 37C 
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(Fig. 17).  These rate constants, however, were both much faster than those observed during the 
reaction of cyanide with CoIIITMPyP(OH)(H2O) (Chapter 3).
When the kinetics of excess 
 
The reaction was followed at 454 nm in 50 mM potassium phosphate buffer, pH 7.4, 1 mM EDTA, at 25C 
and 37°C under conditions of excess cyanide.  Cyanide solutions in the drive syringe were in 5 mM sodium 
tetraborate buffer (pH 11); cyanide concentrations after mixing were 20 to 2500 µM; upon completion of 
reactions, discharged solutions were verified to be pH < 7.45.  The observed rates associated with the two 
fast rate constants (k1 and k2) plotted versus the cyanide concentration at (A) 25°C (B) 37°C. Rate constants 
(see Table 2) were then obtained from the slopes of the plots. 
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Figure 17: Kinetics of the reaction of cyanide with CoIITMPyP under pseudo first 
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Table 2: Second order rate constants and absorbance amplitudes for the formation of 
CoIIITMPyP(CN)2 from Co
IITMPyP at 25-37°C, pH 7.4 in 0.1 M sodium phosphate buffers.
Conditions 
Phase 1 Phase 2 Phase 3 Phase 4 
k1 (M
-1s-1) A% k2 (M
-1s-1) A% k3 (M
-1s-1) A% k4 (M
-1s-1) A% 
pH 7.4, 25 C 800 (±90) 22 263 (±52) 23 9 (±1) 8 0.35 (±.05) 46 
pH 7.4, 37 C 2500 (±600) 18 800 (±100) 27 20 (±3) 7 0.7(±.05) 48 
pH 7.4, 25 C* 111 (±7) 6 29 (±1) 40 9 (±1) 8 0.35(±.05) 46 
The observed kinetics could be resolved into four exponential phases.  Rate constants are calculated from 
linear fits of observed rates to the cyanide concentration as shown in Figure 17 (cyanide was in at least 20-
fold excess over porphyrin).  The percent absorbance change (amplitude) for each phase is also given.  
Uncertainties shown in parentheses are standard deviations. The last row contains the rate constants for the 
binding of cyanide to the oxidized form of the porphyrin  (CoIIITMPyP) for comparison(*)). 
When the kinetics of excess cyanide binding to CoIITMPyP were compared in the
presence and absence of bovine serum albumin (BSA), a component of plasma, the initial rates 
were found to be indistinguishable for the first 15 minutes (Fig. 18).  After 20 minutes, however, 
where essentially 80% of the reaction is complete, the cyanide binding in the presence of BSA is 
somewhat slower. It was previously shown that the last phase (described by k4) of cyanide 
binding to CoIIITMPyP is dependent upon ionic strength and therefore it might be expected to
observe some changes in cyanide binding with BSA present. Whatever the complexity of the 
overall reaction, the key findings in relation to the kinetics of the reaction between CoIITMPyP
and cyanide are:  (i) cyanide binding is facile (Figure 17); (ii) the reaction is little affected by the 
presence of either oxygen (not shown) or the serum component protein BSA (Figure 18); and 
(iii) it occurs in blood (Figures 15C and 15D). 
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Figure 18: The rate of cyanide binding in the presence (solid circles) and absence (open circles) of 
BSA. 
Conditions: 3.48 µM CoIITMPyP in 50 mM sodium phosphate buffer, pH 7.4, 1 mM in EDTA and 0.1 mM 
in NaCN, 25°C.  Reaction was followed spectrophotometrically at 454 nm. 
4.4 DISCUSSION 
The reduction of CoIIITMPyP(OH)(H2O) is facile and easily carried out by ascorbate,
with a rapid pseudo-first order rate constant of 1.4 x 105 M-1 s-1 at physiological pH and
temperature (Figure 13).  The appearance of an EPR signal with characteristics corresponding to 
the reduced form of CoIITMPyP in mouse blood (Figure 15), where the ascorbate concentration
is near 60 M, also lends evidence to this occurring under physiological circumstances. 
Therefore, if CoTMPyP is used as an antidote to cyanide toxicity, its ability to bind cyanide in 
the reduced form is important.  Many of the results presented in this paper led to the conclusion, 
however, that cyanide rapidly catalyses the conversion of the reduced CoIITMPyP to the oxidized
(CoIII) forms, leading to CoTMPyP exhibiting the same binding affinity for cyanide irrespective
of the initial oxidation state (CoII, or CoIII).  The cyclic voltammetry experiments demonstrated
that CoTMPyP in the presence of cyanide had a cathodic wave but no corresponding anodic 
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wave (Figure 14), indicating that another, quite rapid mechanism, exists to convert CoIITMPyP
to the CoIII analog.  When cyanide is added to CoIITMPyP, only a transient EPR signal
corresponding to CoIITMPyP(CN) is observed, again suggesting oxidation, as CoIIITMPyP is
EPR silent (Figure 15).  Frequently oxygenation, oxidation and reduction of CoIITMPyP leads to
the formation of -peroxo bridged dimers, which are EPR silent.  These take many hours to 
form, however, which is certainly not the case in these studies, as the disappearance of the CoII
EPR signal is rapid – also the present reaction is not oxygen sensitive.  Furthermore, when 
cyanide was added to CoIITMPyP in substoichiometric amounts, CoIITMPyP was converted to
CoIIITMPyP(OH)(H2O) as shown in the electronic absorption spectra shown in Figure 16A.  In
addition, the binding constant calculated from titrations of CoTMPyP in ascorbate is very similar 
to that obtained for the oxidized form of CoTMPyP (K = 2.0 x 10
10, Fig.16B).  All of these
results add compelling support to the argument that cyanide catalyses the oxidation of 
CoIITMPyP.
The precise mechanism of cyanide induced oxidation of CoIITMPyP remains unclear.
The results of kinetic studies of the reaction of CoIITMPyP with excess cyanide proved to be
quite complicated (Table 2).  Chan et al.77 in their radiation reduction experiments found the
porphyrin ring contained a π-anion radical.  No evidence for a π-anion radical in either the 
electronic absorption or EPR spectral data of the present samples were found.  If the π-anion 
radical was formed, however, it may be very unstable in aqueous solution and rapidly react with 
water or protons.  An attractive notion for a disproportionation mechanism is having cyanide act 
as a bridging ligand in order to facilitate an electron flow, for example: 
TMPyPCoII-CN-CoIITMPyP   TMPyPCoI-CN-CoIIITMPyP
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There are many known examples of cyanide forming bridges between metallo-macrocycles87,88
and other metal complexes.89-91  If CoII disproportionates in this manner, however, it is not clear
how the CoI form is subsequently converted to CoIII as indicated by the data.  When the reaction
of CoIITMPyP was conducted with cyanide anaerobically, no difference in the rate of reaction
was found, indicating that oxygen was not involved.  Therefore, the mechanism cannot involve 
the formation of a μ-peroxo-bridged dimer intermediate as observed in other cases.87-91 Thus, by
a process of elimination, the following reaction (that would remain undetected by cyclic 
voltammetry in solvent water) to explain the oxidation of CoITMPyP to CoIIITMPyP remains:
CoITMPyP (CN) + 2 H+     CoIIITMPyP(CN) +  H2
Now, leaving aside the details of the oxidation-reduction components of the net reaction 
and restricting the discussion primarily to consideration of the ligand exchange processes, it 
seems that there are two broad types of plausible mechanism that fit these observations (Schemes 
I and II of Figure 19).  It is inferred from the observed rate of CoIIITMPyP reduction by
ascorbate (Figure 13) that oxidation-reduction reactions are faster than the ligand substitutions in 
these complexes and thus, only the latter should be rate determining.  Scheme I is the simplest, 
where the parentheses enclosing one axial aquo ligand of the initial CoIITMPyP complex should
be taken to indicate uncertainty as to whether this species is 5- or 6-coordinate.  Substitution of 
the aquo ligand(s) by the first cyanide anion, with the associated rate constant k1, leads to the 5-
coordinate CoIITMPyP(CN) intermediate detected by EPR spectroscopy.  Substitution of the
second cyanide anion is characterized by the rate constant k2, accompanied by rapid oxidation to 
the final product CoIIITMPyP(CN)2.  The alternate possibility, Scheme II, involves the initial
rapid formation of the EPR-detectable CoIITMPyP(CN) intermediate, followed by two discrete
rate-determining pathways.  One involved substitution of the second cyanide and accompanying 
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oxidation as in Scheme I. but now characterized as k1 rather than k2.  The other pathway involves 
first oxidation of CoII to CoIII followed by the second cyanide substitution with associated rate
constant k2.  There are two obvious problems with Scheme II.  The electron transfer reaction 
must be slow enough to be comparable with k1, or only k2 would be apparent in the kinetic 
traces.  Also, the present k2 should be the same rate constant as k2 in the reaction starting from 
the oxidized CoIIITMPyP(OH)(H2O) (Chapter 3) but the numerical results for these two
constants differ by a factor of about 9 and, consequentially, Scheme I is favored. 
Figure 19: Plausible schemes for the two fastest phases of the reaction between CoIITMPyP and HCN 
at pH 7.4. 
While most of the results in this work revolve around the cobalt porphyrin, CoTMPyP, 
the cyclic voltammetry of cobinamide has also been included for comparison (Figure 14B).  
Cobinamide is also reduced rapidly by ascorbate (k ~ 1.4 x 102 M-1s-1) and its cyclic
voltammogram exhibits similar characteristics to that of CoTMPyP (Figure 14A); that is, in 
neither case is an anodic wave detected.  While the titration behavior (data not shown) is more 
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complicated, cobinamide also appears to undergo a cyanide catalyzed disproportionation 
reaction.  Therefore, it is expected that cobinamide and CoTMPyP will be reduced in vivo but 
that upon exposure to cyanide, these compounds will rapidly be converted to their CoIII forms
and bind cyanide with almost the same affinity as if the starting material were the oxidized 
species.  This is fortuitously advantageous, since one obtains the more rapid substitution kinetics 
of the CoII forms along with the higher binding affinities of the CoIII forms.
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5.0  CONCLUSIONS 
Cyanide Antidotes:  In the U.S. cyanide antidotes are required for treating victims of 
potential occupational accidents, infrequent ingestions (attempted murder/suicide) and fire 
smoke inhalation cases.  Ingestion of cyanogenic plants by livestock is a veterinary concern, 
particularly associated with post-drought new growth and, thus, is likely to increase in frequency 
and severity under the influence of global warming.  In addition to the FDA approved use of 
cobalamin and the nitrite-thiosulfate combination, there are a few other potential cyanide 
antidotes in various stages of development, including cobinamide, sulfanegen sodium, and -
ketoglutarate.30,35,38 This is almost certainly too few.  Cobalamin is expensive and has only
modest affinity for cyanide, hence the interest in cobinamide.63  In the case of the nitrite-
thiosulfate combination there are emerging toxicity issues.20  For reasons of cost effectiveness,
inappropriate pharmacokinetics, or toxicity, more than 90% of candidate compounds having 
promising therapeutic properties are, ultimately, never approved and marketed.  Consequently, it 
is desirable to have dozens of candidate compounds under development to ensure a reasonable 
chance of success in the search for new cyanide antidotes.
Rational Development Strategy:  Nowadays, there is a good deal of effort put into 
combinatorial approaches and high-throughput screening of libraries in the search for 
pharmaceuticals.  This can certainly sometimes work, particularly in the search for compounds 
such as noncompetitive inhibitors of enzyme function, but relies on good luck.  Screening can 
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both miss suitable compounds and give false positives; moreover, one can only discover the best 
candidate leads in the available libraries, which might be far from ideal or optimal.  The task at 
hand is to find compounds that either bind or convert cyanide to less toxic forms.  This is a 
chemically tractable problem and should be amenable to rational design – that is, take 
compounds with the desired activity, identify any undesirable characteristics of their chemistry, 
then modify the molecules in such a way as to suppress those undesirable characteristics while 
retaining and/or improving the desired activity.  Herein, it has been shown that any cobalt–
containing macrocyclic compound in which the CoIII form is more stable than the CoII form
probably has potential as an antidote to cyanide toxicity and the task becomes one of selecting 
one or more such lead compounds to modify in order to eliminate any undesired characteristics.  
For example, Busch and co-workers have synthesized many macrocycles into which cobalt can 
be inserted.44
Amido-linked Macrocycles:  Initially, it was considered that structures derived from 4-
nitrophenylenediamine and isophthaloyl dichloride (Figure 2) would be near ideal cyanide 
scavenger compounds.  Stable molecules straightforwardly synthesized in one or two steps from 
readily available and inexpensive starting materials (e.g., Figure 2) appeared particularly good 
candidates for stockpiling.  Some considerable effort to develop these as candidates was 
expended before these endeavors were suspended due to their low solubility and consequent 
practical difficulty of purifying such compounds in reasonable amounts.  Macrocyclic amido-
linked structures are, however, known to stabilize higher oxidation states of chelated metal 
ions.41 At the outset this looked like an attractive property, but is no longer considered a
desirable characteristic.  Now it is suspected that the ability of the functioning scavengers to bind 
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cyanide in their CoII forms before becoming oxidized to stable CoIII forms to be mechanistically
important (Chapter 4).
Corrinoids:  Cobalt-corrins like cobalamin and cobinamide certainly work, but are less 
than ideal.  In particular, they are expensive to produce and not especially stable, rendering them 
unsuitable for stockpiling.  Less expensive alternatives, even of similar activity, would be 
beneficial.
Phthalocyanines:  Cobalt-phthalocyanines do not work, binding cyanide only very 
slowly if at all (Chapter 1.3.2)  The tendency of the phthalocyanine ring to stabilize the CoII
forms of these complexes may contribute to the low reactivity, but these structures were 
eliminated from further consideration as potential candidates without any more detailed 
investigation of their mechanistic properties. 
Porphyrins:  Herein, it has been shown that, despite any earlier suggestions to the 
contrary,54 cobalt-porphyrins do work as cyanide antidotes (Chapter 3).  This was, however,  a
proof-of-concept study, as CoTMPyP is not a practical candidate for further development.  The 
antidotal activity was demonstrated at a dose of 20% of the LD50 for this compound (Figure 11) 
representing a therapeutic index (TI) of only 5.  A TI of less than 10 is usually taken to indicate a 
“no go” decision should be made regarding further development of the compound in question.  
For this reason, additional studies of the pharmacokinetics of CoTMPyP in mice were not 
undertaken.  There was, however,  no unusual discoloration of the urine noticed in experimental 
animals within 1-2 hours of receiving CoTMPyP doses (i.p.) suggesting there was no significant 
excretion of the compound on the timescale of the experiment, since the kidneys are the 
predominant excretion pathway for water-soluble porphyrins and phthalocyanines.44,45
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The failure of CoTMPyP to work as a prophylactic cyanide antidote when given 15 
minutes prior to the toxin54 remains unexplained.  The idea that this may be due to inactivation of
the administered CoIIITMPyP by reduction to CoIITMPyP has been shown to be unfounded
(Chapter 4).  In fact, it is possible that the CoTMPyP does not become inactivated at all within 
15 minutes.  An undesirable characteristic of the structure is that its solubility in water is 
achieved by the introduction of four positively charged groups on the periphery of the ring.  This 
is likely to render the molecule susceptible to sequestration into mitochondria where it may well 
have toxic consequences (Lopez, Benz et al., manuscript in preparation).  It follows that if 
sequestration into mitochondria is significant within 15 minutes, the previously observed 
“failure” to observe any prophylactic benefits of CoTMPyP in cyanide intoxication of mice54
might in fact have been due to a synergistic toxicity on CNS mitochondria of cyanide plus 
CoTMPyP. 
Schiff Base-linked Macrocycles:  Busch and co-workers have reported the synthesis 
numerous macrocycles into which cobalt can be inserted in a one-step template synthesis 
followed by purification in a single recrystallization.44 Typically, these compounds readily
exhibit reversible CoII/CoIII redox chemistry – a characteristic now considered to be important
(Chapter 4).  Many of these compounds are soluble in water and zwitterionic forms are 
accessible to prevent/suppress any tendency to partition into mitochondria.  The structures often 
contain one or more six-membered aromatic rings (Figure 20).  Starting materials with different 
aromatic ring substituents provide a convenient means to fine tuning the characteristics of the 
macrocyclic products.  In general, the molecular masses of the Schiff base-linked macrocycles 
are about half those of the porphyrins and naturally-occurring corrinoids.  One or more of these 
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cobalt-containing Schiff base-linked macrocycles would appear to be highly suitable candidates 
as lead compounds for future studies in the search for improved cyanide antidotes. 
Figure 20: Representative Schiff base-linked macrocycles that are hypothetically suitable as cyanide 
antidotes. 
 Busch96 synthesized the compound at left while Curtis97 produced the compound at right. 
Future Direction:  The driving force (and funding) behind this work was the threat of 
chemical terrorism involving cyanide and the projected need to develop effective treatment 
options for mass casualties.  During the course of the project, many of the leaders of the terrorist 
organization at the center of the perceived threat have been eliminated and the level of concern 
has abated.  From a Public Health perspective there are two principal remaining issues with 
regard to cyanide toxicity.  HCN is a significant toxic component of modern fires and smoke 
inhalation victims are probably the most frequent patients exhibiting symptoms of acute cyanide 
toxicity presenting at emergency rooms in Europe and the U.S.1,92  In relation to the
underdeveloped world, ingestion of cyanides and consequent chronic toxicity from food and 
possibly the water supply is an ongoing matter of international concern amongst policy 
makers.93-95  Surprisingly, despite the obvious high level of worry, the relationships between
relatively low-level chronic cyanide toxicity and its possible resulting human health issues are 
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very poorly documented and even less well understood.  Improved understanding of the 
mechanism(s) of chronic cyanide toxicity at the molecular level, the long-term sequelae 
stemming from such exposures and the development of effect medical interventions/behavioral 
practices to prevent/treat these conditions are the areas where more research efforts need to be 
directed in the future. 
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